Eximo Medical's B-Laser Atherectomy System Successfully Used to Cross CTOs Without a Guidewire

 

May 13, 2019—Eximo Medical Ltd. announced the first successful use of the company's B-Laser atherectomy system in a step-by-step approach (eg, crossing a noncrossable chronic total occlusion [CTO] cap without a guidewire) to treat patients with highly complex, arterial occlusive peripheral artery disease (PAD). Additionally, the company noted the first use of Eximo's on-line photoacoustic monitoring to enhance safety during the procedures.

In January 2019, Eximo Medical announced the launch and first commercial use of the B-Laser atherectomy system for treatment of peripheral vascular disease. According to the company, the B-Laser technology enables a step-by-step crossing approach using a standard B-Laser catheter followed by atherectomy with the same catheter while using standard guidewires.

Professor Waclaw Kuczmik, MD, Professor of Surgery at the Medical University of Silesia in Katowice, Poland, led a clinical study that successfully, without any complications, used the B-Laser in several such cases, including long and severely calcified lesions. In addition, these procedures included the use of Eximo’s future on-line photoacoustic signal monitoring technology, which employs machine learning that will allow interventionalists to characterize the material in contact with the catheter tip and provide a warning signal to avoid vessel injury and procedural complications.

Luis Leon, MD, a vascular and endovascular surgeon at PIMA Vascular in Tucson, Arizona, has begun to use the B-Laser to treat patients affected by highly complex, highly calcific lesions at both the above- and below-the-knee artery segments, that includes antegrade and retrograde pedal approaches.

In the company's announcement, Dr. Leon commented, “There is a well-known paucity of devices that allow interventionalists to cross occlusive lesions in an intraluminal path as opposed to subintimal. I am very excited to work with Eximo using the B-Laser in a variety of PAD patients and to incorporate it routinely in our outpatient-based laboratory. The capability to cross chronically occluded arteries without needing to cross with a wire first, and to then be able to perform atherectomy over a wire by using the same catheter represents a welcomed and significant addition to our toolkit as it addresses a real unmet need in our practice. I am very proud to be part of this exciting technology and journey.”

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.